HSP90AA1 and neoplasm: Several classes of inhibitor were screened against B. pahangi or B. malayi lysates, as well as human Hsp90α, using the FP assay originally developed as a high throughput screen for Hsp90 inhibitors in tumor cells, as previously applied to Brugia[12].